Literature DB >> 17850024

[Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats].

D A Vilenskiĭ, N G Levitskaia, L A Andreeva, L Iu Alfeeva, A A Kamenskiĭ, N F Miasoedov.   

Abstract

Effects of chronic intranasal administration of ACTH(4-10) analog Semax (MEHFPGP) on exploratory activity, anxiety level, and depression-like behaviour were studied in white rats. The peptide was injected daily in dose 0.05 mg/kg during 10 or 14 days. It was shown that chronic Semax administration at 1-2 weeks induced anxiolytic and antidepressant effects but did not influenced the exploratory activity in non-stressogenic environment. The Semax effects may be the results of activation of the brain serotoninergic system as well as increased BDNF expression in the rat hippocampus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850024

Source DB:  PubMed          Journal:  Ross Fiziol Zh Im I M Sechenova        ISSN: 0869-8139


  4 in total

1.  Neurotropic activity of ACTH(7-10)PGP, an analog of an ACTH fragment.

Authors:  N Yu Glazova; M S Atanov; A V Pyzgareva; L A Andreeva; D M Manchenko; D D Markov; L S Inozemtseva; O V Dolotov; N G Levitskaya; A A Kamensky; I A Grivennikov; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2011-12-02

2.  Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats.

Authors:  K A Yatsenko; N Yu Glazova; L S Inozemtseva; L A Andreeva; A A Kamensky; I A Grivennikov; N G Levitskaya; O V Dolotov; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2014-01-03

3.  Semax corrects brain dysfunction caused by prenatal introduction of valproic acid.

Authors:  A V Malyshev; E V Razumkina; V A Dubynin; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2013-07-03

4.  Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism.

Authors:  P A Slominsky; M I Shadrina; T A Kolomin; A V Stavrovskaya; E V Filatova; L A Andreeva; S N Illarioshkin; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2017-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.